PROTRANSIT NANOTHERAPY LLC
Topical nanotherapy delivery system (Pro-NP™) for sustained release of antioxidant enzymes (SOD and CAT) to prevent UV-induced skin damage and cancer
- Sector
- Medtech
- Headquarters
- Omaha, NE
- Total capital
- $782K
- Federal grants
- $782K
- 3 awards · 2020–2021
- Rank in peer group#13 of 36
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · A novel antioxidant delivery system, Pro-NP™, for protection against UV-related skin cancer$261K
- Federal grantHealth and Human S · Phase I · A novel antioxidant delivery system, Pro-NP™, for protection against UV-related skin cancer$261K
- Federal grantHealth and Human S · Phase I · Antioxidant enzyme-loaded Pro-NP for treatment of TBI.$260K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianMedtech · Material
- Federal grants#13 · top 36%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 5- PendingCyclosporine Compositions And Methods Of Use ThereofUSPTOApplication 18287762
- PendingCompositions And Methods For The Treatment Of Hair Loss And Other ConditionsUSPTOApplication 18246572
- PendingCyclosporine Compositions And Methods Of Use ThereofUSPTOApplication PCTUS2022033404
Show all 5 patent records
- Cyclosporine Compositions And Methods Of Use ThereofJun 13, 2024 · Application 18287762Pending
- Compositions And Methods For The Treatment Of Hair Loss And Other ConditionsNov 23, 2023 · Application 18246572Pending
- Cyclosporine Compositions And Methods Of Use ThereofApplication PCTUS2022033404Pending
- Cyclosporine Compositions and Methods of Use ThereofApplication 63210250Pending
- Compositions and Methods for the Treatment of Hair Loss and Other ConditionsApplication 63082613Pending
Related companies, and why
- RESOLET LLCSimilar federal contract value in Medtech · null in contracts
- Tactile Analogics LLCSimilar federal contract value in Medtech · null in contracts
- YENOS ANALYTICAL, LLCSimilar federal contract value in Medtech · null in contracts
- BEAM - CA, LLCSimilar federal contract value in Medtech · null in contracts
- Venova Medical IncSimilar federal contract value in Medtech · null in contracts
- BIOMEDICAL ACOUSTICS RESEARCH COMPANYSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .